Welcome to the Series B-hive
So far, 2023 has been the year of unlabeled raises and extension rounds—but the summer's venture funding has us wondering whether the Series B is back. Over the past couple of months, Series B rounds were raised by Daybreak Health ($13M), Verifiable ($27M), Proprio Vision ($43M), Thyme Care ($60M), and Nursa ($80M). Back in H1 2022, we speculated that bigger early stage checks could lead to a crunch in subsequent raises; this recent return of the Series B illustrates how some savvy startups are responding to the market, leveraging rapid commercial growth and major enterprise partnerships to cross the Series B threshold. For the remainder of Q3, we'll be watching to see which companies make the Series B leap—and who stays in Series A (extension) land.
Headlines
As The Obesity Drug Market Grows, Digital Health Companies Juggle Patients And Payers
Payers and employers have a vested interest in preventing quick scripts STAT
AWS Launches Interactive Healthcare Cloud Training
More than 30 programs aim to address the healthcare skills gap Healthcare IT News
Employers' Enthusiasm For Virtual Care Is On The Decline
Worry that virtual care platforms are siloed from other sites of care Fierce Healthcare
Epic, Microsoft Expand Partnership To Accelerate Generative AI In Healthcare
Dozens of new tools to be rapidly deployed Healthcare Dive
Recent Funding
- Employee health and wellness solution Gympass raises another $85M
- Per-diem nurse staffing marketplace Nursa secures $80M
- Value-based cancer care navigation solution Thyme Care nabs $60M
- Kyros Health collects $10.5M for its digital substance use disorder care management platform
- Practice management and CRM software solution Keona Health bags $7M
- Clinetic adds $5M for its EHR-based data, analytics, and insights software for life sciences
- Zivian Health grabs $3M to connect nurses and PAs with collaborating physicians
- GPT-based healthcare model developer Synthpop seeds $2.6M